Filing Details

Accession Number:
0001415889-24-024676
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-03 19:03:40
Reporting Period:
2024-10-02
Accepted Time:
2024-10-03 19:03:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1422142 Aadi Bioscience Inc. AADI Pharmaceutical Preparations (2834) 611547850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1995275 James David Lennon C/O Aadi Bioscience, Inc.
17383 Sunset Boulevard, Suite A250
Pacific Palisades CA 90272
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-10-02 32,558 $0.00 32,558 No 4 M Direct
Common Stock Disposition 2024-10-03 9,689 $1.94 22,869 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2024-10-02 32,558 $0.00 32,558 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.
  2. Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
  3. One hundred percent (100%) of the RSUs subject to the award vested on October 2, 2024.